Mirati Therapeutics reported $24.27M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Astellas Pharma 4503:JP Y 152220M 21481M
Bayer BAYN:GR 5.85B 945M
Bristol Myers Squibb BMY:US $ 2882M 62M
Eisai 4523:JP Y 96106M 66475M
Eli Lilly And LLY:US $ 1659.3M 226M
Exelixis EXEL:US $ 17.28M 6.97M
Moderna Inc MRNA:US 181M 18M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Novartis NOVN:VX 4.97B 114M
Puma Biotechnology PBYI:US $ 9.84M 2.43M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Seattle Genetics SGEN:US $ 128.87M 41.64M
Spectrum Pharmaceuticals SPPI:US $ 25.3M 8.1M
Takeda 4502:JP Y 424358M 91939M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
YTE INCY:US $ 194.77M 42.22M